International Plasma Awareness Week IN Europe
Learn about International Plasma Awareness Week celebrations and resources in Europe.
We may all need a donation at some point, and so I say to myself, 'Why not?'
About ipaw IN europe
In the coming decade, more European patients are expected to need access to plasma-derived medicines. This makes IPAW an important chance to raise awareness for the power of plasma-derived medicinal products (PDMPs) and the patients who rely on them.
Every year, more patients across the EU are diagnosed with life-threatening plasma protein-related disorders, such as immune deficiencies, immune-mediated peripheral neuropathies, hereditary angioedema, alpha-1 antitrypsin deficiencies, haemophilia, von Willebrand disease, and more.
In many cases, plasma-derived medicines are the only option to treat these rare diseases. New indications, improved diagnostic techniques, greater use in Europe, and increased use in cancer treatment-induced secondary immunodeficiency contribute to a growing clinical need. IPAW helps shine a light on this growing demand, and on plasma donation in Europe.
Across Europe, donor centers and patient organizations are hosting activities to raise awareness during IPAW. Click below to find a donor center near you, and reach out to learn if they are planning events or celebrations.
.png)
Find a donation cenTER
Locate your nearest plasma center by entering a city or a postal code of your area in the search bar below.
.avif)
%202.png)
Read Blog Posts
Get news, stories, and more from the PPTA blog during International Plasma Awareness Week.
.avif)
Share Powerful Stories During #IPAW2024
Decorate Your Space for #IPAW2024!
Stay Connected on Social Media During #IPAW2024
.png)
Raise Awareness
Other ways to get involved in Europe during IPAW include.
Learn Why the EU Needs More Plasma
Every year, more patients across the EU are diagnosed with life-threatening plasma protein-related disorders, such as immune deficiencies, immune-mediated peripheral neuropathies, hereditary angioedema, alpha-1 antitrypsin deficiencies, haemophilia, and other bleeding disorders. In many cases, plasma-derived medicines are the only option to treat these rare life-threatening diseases. New indications, improved diagnostic techniques and increased use in cancer treatment-induced secondary immunodeficiency also contribute to the growing clinical need for plasma-derived medicines across Europe. Learn more.
Post on Social Media
Post about #IPAW2024 on your favourite social media platforms to raise awareness about plasma donation and the power of plasma-derived therapies. Get started right away with a pre-scripted tweet for X (Twitter), (Note: You must be logged into Twitter for the text to populate.) or find more content with a social media toolkit.
Raise Awareness with Policymakers
European health care patients need continued access to PDMPs, secure supply chains, and increased plasma collection in Europe. Use this sample letter to share why this is important. This template is designed to be adaptable to you or your organisation, with options to include important information relevant to your specific region or health condition.
Share Your Story
Are you a plasma donor or a patient who uses plasma-derived medicines? Click here to share your story for a chance to have it shared on PPTA’s social media channels, email newsletters, or other communications outlets.